| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 12.751 | 20.435 | 28.612 | 27.553 | 49.659 | 61.938 | 72.890 |
| Total Income - EUR | - | - | - | 12.751 | 20.435 | 28.612 | 27.553 | 49.659 | 61.938 | 72.890 |
| Total Expenses - EUR | - | - | - | 478 | 538 | 551 | 546 | 608 | 8.422 | 9.342 |
| Gross Profit/Loss - EUR | - | - | - | 12.273 | 19.897 | 28.062 | 27.008 | 49.051 | 53.515 | 63.548 |
| Net Profit/Loss - EUR | - | - | - | 11.891 | 19.284 | 27.267 | 26.181 | 47.809 | 52.908 | 61.405 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Otolarimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 12.408 | 20.068 | 47.021 | 45.451 | 48.495 | 54.576 | 67.118 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 10.431 | 18.515 | 44.488 | 43.327 | 42.834 | 43.351 | 50.978 |
| Cash | - | - | - | 1.977 | 1.552 | 2.533 | 2.124 | 5.661 | 11.226 | 16.140 |
| Shareholders Funds | - | - | - | 11.934 | 19.334 | 27.316 | 44.728 | 47.858 | 52.956 | 61.454 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 474 | 733 | 19.704 | 723 | 637 | 1.620 | 5.665 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Otolarimed S.r.l.